跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JAMP DOCUSATE S OBLONG - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
JAMP DOCUSATE S OBLONG
Authorized
STANDARD
JAMP DOCUSATE S OBLONG
Jamp Pharma Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1a990528898e5af3
Company
Jamp Pharma Corporation
Type
Standard
Approval Details
Approval Id
1a990528898e5af3
Drug Approval Canada Name
JAMP DOCUSATE S OBLONG
Product Name
JAMP DOCUSATE S OBLONG
Status
Cancelled Post Market
Status Date
2022-09-02
Original Market Date
2016-04-12
Din
02376121
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
OTC
Ahfs
56:12.00
Atc Original
A06AA02 DOCUSATE SODIUM
Atc Name
a 06 aa 02
Aig Number
0104351002
Company Name
Jamp Pharma Corporation
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Company Detail Path
/organization/jamp-pharma-corporation
Company Information
Pharmaceutical Company Name
Jamp Pharma Corporation
Country Name
Canada
Province Name
British Columbia
City Name
chilliwack,british columbia,country_ca
Address
8065 Aitken Rd
Active Ingredients
DOCUSATE SODIUM
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1a990528898e5af3
Type
Standard
Back to Health Canada Approvals